Over 20 years of professional research

Leading the future of healthcare and opening up biological innovation

Focusing on the chemical industry | 20000+spot inventory | Standardized management process

We Focus On

The Reagent Biochemistry Industry

We strengthen the supply chain to ensure quality and productcompliance

Efficiently connect with global customer needs

Shanghai Chemlin Biopharmaceutical Co., Ltd. was established on November 15, 2020. With over 25 years of careful cultivation by Nanjing Chemlin Chemical Industry Co., Ltd., the company has established a good corporate image, built a comprehensive chemical business network, and cultivated a professional workforce. Shanghai Chemlin will focus on a high-level R&D team, specialized customized production layout, and an efficient service system that connects the world. Expand cooperation in research and development, production, and trade related to chemicals in multiple fields, with a focus on exploring international markets in various regions.

View

Employees Number

1000+

Catalog Number

1.2m+

Cover An Area

2000m²

Cooperative Partner

5000+

Our Service

Hand in hand, lead the way of life and health with science. Chemlin Biopharmaceutical Company has a wide range of scientific research product portfolios, advanced drug research and manufacturing capabilities, and a fully integrated service platform for traditional and new pharmaceuticals in the industry. We are committed to benefiting the world with innovative products, high-quality services, and digital solutions, and creating a sustainable future for the next generation.

Medical Discovery

Chemlin Biopharmaceutical has a professional R&D team with high education and rich experience, which can continuously develop new products according to market demand to meet the needs of more customers.

Drug Development

The application field of the company's products is the research and development of biomedicine, which is used for target discovery in new drug development, screening and optimization of promising compounds, and screening and optimization of lead compounds.

Drug Production

We have internationally advanced production equipment and a strict quality management system to ensure that every drug meets the highest standards throughout the entire process from raw materials to finished products.

Core Technology

The core technology of the company is based on the research and development, design, synthesis, production, detection and purification technology of drug molecular blocks, continuously enhancing the ability of molecular structure confirmation detection and purity detection.

Featured Products

Featured Products Promotional Products

KL-J250515-539

tert-butyl N-[1-(3-hydroxypropyl)-1H-imidazol-2-yl]carbamate

95%

$780 0.05g

KL-J250515-647

tert-butyl 4-(bromomethyl)-2,2-dimethylazetidine-1-carboxylate

95%

$232 0.05g

KL-J250515-700

3-fluoro-2-hydroxy-5-(methoxycarbonyl)-4-methylbenzoic acid

95%

$912 0.05g

KL-A250519-026

rac-(3R,4S)-4-hydroxy-1,1-dioxo-1lambda6-thiolane-3-carboxylic acid

95%

$419 0.05g

KL-A250519-035

ethyl 2-(2-sulfanylidene-2,3-dihydro-1H-imidazol-1-yl)acetate

95%

$671 0.05g

KL-J250515-575

tert-butyl 2-(pent-4-yn-1-yl)pyrrolidine-1-carboxylate

95%

$205 0.05g

KL-J250515-548

tert-butyl N-[7-(hydroxymethyl)-3-oxabicyclo[3.3.1]nonan-9-yl]carbamate

95%

$935 0.05g

KL-J250515-584

1-(6-bromo-5-chloropyridin-3-yl)methanamine dihydrobromide

95%

$88 0.05g

KL-J250515-674

rac-1,3-dimethyl (1R,3R,4R)-bicyclo[2.2.0]hexane-1,3-dicarboxylate

95%

$344 0.05g

KL-J250515-683

methyl 8-benzyl-4,4,5-trifluoro-7,9-dioxo-8-azatricyclo[4.3.0.0,2,5]nonane-2-carboxylate

95%

$524 0.05g

KL-J250515-692

5-chloroquinoxaline-6-carbaldehyde

95%

$935 0.05g

KL-J250515-728

4-(difluoromethoxy)-2,6-dimethoxy-3-(methoxycarbonyl)benzoic acid

95%

$1080 0.05g

KL-J250515-746

2-(5-bromo-2-methylphenyl)propan-1-amine hydrochloride

95%

$160 0.05g

KL-J250515-566

4-methoxy-3-nitro-5-(trifluoromethyl)benzene-1-sulfonyl fluoride

95%

$0 1g

KL-J250515-665

2-[(methylamino)methyl]-3,4-dihydro-2H-1-benzopyran-6-carboxylic acid

95%

$935 0.05g

KL-J250515-719

rac-tert-butyl (2R,3S)-3-amino-2-(4-methoxyphenyl)pyrrolidine-1-carboxylate

95%

$1212 0.05g

A top-notch research team and advanced R&D platform provide integrated solutions from R&D to production, meeting diverse customer needs and maintaining a leading position in the field of drug innovation. We have world-class production facilities and a strict quality management system to ensure that every product meets the highest standards.

Quality System

We have established a comprehensive quality management system that covers the entire process from raw material procurement to production, testing, and delivery. By strict standard control and continuous improvement, we ensure the high quality and consistency of our products. We adhere to the concept of "quality first", with customer satisfaction as our goal, constantly improving our quality management level, and providing reliable products and services to the market.

Global Service, Precise Supply

Through a comprehensive logistics network and intelligent management system, we ensure that products are delivered quickly and accurately to all parts of the world. Whether it's local needs or cross-border cooperation, we are able to respond flexibly and meet the diverse needs of our customers. Global service and precise supply are our commitment to customers and our continuous pursuit of goals.

Environmental Protection Production, Responsibility First

We always prioritize responsibility and integrate green concepts into every aspect of production. By adopting clean energy, optimizing process flow, and reducing waste emissions, we are committed to reducing our impact on the environment. At the same time, actively fulfilling social responsibilities, promoting the green transformation of the industry, and creating a better ecological environment for future generations

Continuous Innovation, Leading Technology

Kangmanlin Biopharmaceutical Company has always been driven by technological innovation and committed to leading the future development of the biopharmaceutical industry. We have gathered top global research teams, continuously increasing R&D investment, breaking through technological bottlenecks, and creating efficient and precise pharmaceutical solutions.